4.3 Review

Management of morning hypertension: a consensus statement of an Asian expert panel

Journal

JOURNAL OF CLINICAL HYPERTENSION
Volume 20, Issue 1, Pages 39-44

Publisher

WILEY
DOI: 10.1111/jch.13140

Keywords

ambulatory blood pressure; antihypertensive treatment; home blood pressure; morning blood pressure; morning hypertension

Funding

  1. Bayer
  2. Boehringer-Ingelheim
  3. Daiichi-Sankyo
  4. MSD
  5. Novartis
  6. Omron
  7. Pfizer
  8. Sanofi
  9. Servier
  10. Fukuda Denshi
  11. Omron Healthcare
  12. Bayer Yakuhin
  13. MSD K.K.
  14. Mochida Pharmaceutical
  15. Novartis Pharma K.K.
  16. Sumitomo Dainippon Pharma
  17. Boehringer Ingelheim Japan
  18. Daiichi Sankyo
  19. Takeda Pharmaceutical
  20. Astellas Pharma
  21. Teijin Pharma
  22. Bristol-Myers K.K
  23. Shionogi

Ask authors/readers for more resources

Morning blood pressure (BP) surge is an important aspect of hypertension research. Morning BP monitoring could be a clinically relevant concept in the therapeutic management of hypertension and in the prevention of cardiovascular complications by defining and treating morning hypertension. Because antihypertensive medication is often taken in the morning, uncontrolled morning BP during the trough effect hours could be a hallmark of inadequate choice of antihypertensive regimen, such as the use of short- or intermediate-acting drugs, underdosing of drugs, or no use or underuse of combination therapy. To improve the management of hypertension in general and morning hypertension in particular, long-acting antihypertensive drugs should be used in appropriate, often full dosages and in proper combinations. The clinical usefulness of antihypertensive drugs with specific mechanisms for morning BP or split or timed dosing of long-acting drugs in controlling morning BP remains under investigation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available